Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP362385.RAecZ8yojuhP-bjMANNsstop870qnInwnV-siOy3nJlWI130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP362385.RAecZ8yojuhP-bjMANNsstop870qnInwnV-siOy3nJlWI130_provenance.
• NP301742.RAjnnCrmPdXoVboWwRrLtlEA-TkQncFXy_UdgGVoKstNU130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301742.RAjnnCrmPdXoVboWwRrLtlEA-TkQncFXy_UdgGVoKstNU130_provenance.
• NP693474.RAjhEfW2fxNJ61z0L9Ve-hQr0ueO1eWaLvQlO7bsS-cnQ130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP693474.RAjhEfW2fxNJ61z0L9Ve-hQr0ueO1eWaLvQlO7bsS-cnQ130_provenance.
• NP275881.RAwRii_iqj3pk5XtGO9RccnNQfbuBawTpPm_dIMHp2cuY130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP275881.RAwRii_iqj3pk5XtGO9RccnNQfbuBawTpPm_dIMHp2cuY130_provenance.
• NP655307.RA7Utyn_pci3QY7nFbLwpXo2s54FF_ED4aWvOj-bN4yWI130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655307.RA7Utyn_pci3QY7nFbLwpXo2s54FF_ED4aWvOj-bN4yWI130_provenance.
• NP925310.RAzVLsNUs-c6awx5rB6UCzU-GSrqWxJP6oZHMzX1HBfXA130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925310.RAzVLsNUs-c6awx5rB6UCzU-GSrqWxJP6oZHMzX1HBfXA130_provenance.
• NP701417.RAXuRAU0oeJ7k-0ymCYB0p0nrY-w43ee_cnt9wuITTsgk130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP701417.RAXuRAU0oeJ7k-0ymCYB0p0nrY-w43ee_cnt9wuITTsgk130_provenance.
• NP701420.RATdhG_uWArntgun6u7QZ732TvlqRA6lByF-ES-jJWtC4130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP701420.RATdhG_uWArntgun6u7QZ732TvlqRA6lByF-ES-jJWtC4130_provenance.
• NP507744.RAJzSBdIi6KCkv5O8snxua9E8qaCO_9C0MhSrk1N9Zz8Y130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP507744.RAJzSBdIi6KCkv5O8snxua9E8qaCO_9C0MhSrk1N9Zz8Y130_provenance.
• NP946378.RAZzJPiYZO9Vs5wmCaI-rUkeYRHeU5murMWZuhI2ndO2o130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946378.RAZzJPiYZO9Vs5wmCaI-rUkeYRHeU5murMWZuhI2ndO2o130_provenance.
• NP946382.RASQ5spNb3P3f3DtAKqMLKoTb5SUrvxO16sTVdm0lgogs130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946382.RASQ5spNb3P3f3DtAKqMLKoTb5SUrvxO16sTVdm0lgogs130_provenance.
• NP700114.RAgzyrF_Rop_s3MjFfRz92opTeERlWVka7l6QsTFoxz38130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP700114.RAgzyrF_Rop_s3MjFfRz92opTeERlWVka7l6QsTFoxz38130_provenance.
• NP700116.RAtWz9T_V31iO5VfshHJtSK8tEhQW6ZLfd_rq-zFAH_m8130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP700116.RAtWz9T_V31iO5VfshHJtSK8tEhQW6ZLfd_rq-zFAH_m8130_provenance.
• NP782522.RAFid33Rijy5rjLDeMHBPgxclp4kaYuaKOFbLHyuVALlg130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782522.RAFid33Rijy5rjLDeMHBPgxclp4kaYuaKOFbLHyuVALlg130_provenance.
• NP635566.RAo-iOSPWDou37FLEI0ccXsiD-quPcSJQIHqCll47ZrrQ130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP635566.RAo-iOSPWDou37FLEI0ccXsiD-quPcSJQIHqCll47ZrrQ130_provenance.
• NP946374.RAjsxDkPZL8Yu0UEutDXS8D-xM4Vt_WBR_VFQxh6_TY1g130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946374.RAjsxDkPZL8Yu0UEutDXS8D-xM4Vt_WBR_VFQxh6_TY1g130_provenance.
• NP946377.RAuJ2PS-dG8Kxp4fjjLBipt50CjH-dBTB3F3VRhCC96gc130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946377.RAuJ2PS-dG8Kxp4fjjLBipt50CjH-dBTB3F3VRhCC96gc130_provenance.
• NP946379.RAlp2jFz8q4QGqOwFTV-l3kDCVEby4Ncq237t_zp3DJ2w130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946379.RAlp2jFz8q4QGqOwFTV-l3kDCVEby4Ncq237t_zp3DJ2w130_provenance.
• NP946380.RAiNGAB77x7n_-j5UJJSUK-fSIeTEDeEtqbLblJ8G22RE130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946380.RAiNGAB77x7n_-j5UJJSUK-fSIeTEDeEtqbLblJ8G22RE130_provenance.
• NP421600.RAKRmV799Y8Cif2PANjvPuuYeNoXQxVA9Tdox4WLkhPUc130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421600.RAKRmV799Y8Cif2PANjvPuuYeNoXQxVA9Tdox4WLkhPUc130_provenance.
• NP421724.RAKGWnEbORQsDO3_4xnPRiqF1HB6ZQTTjDS-27pe6tMvE130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421724.RAKGWnEbORQsDO3_4xnPRiqF1HB6ZQTTjDS-27pe6tMvE130_provenance.
• NP635568.RA1cS-ZjNszkV4kWPD99JSRvA1RQRQEy78g74Rt0GeB8w130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP635568.RA1cS-ZjNszkV4kWPD99JSRvA1RQRQEy78g74Rt0GeB8w130_provenance.
• NP946375.RAJGc7omk3V6rOWWaivFbTWHdNjBIUTEFini0AGzh5yvQ130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946375.RAJGc7omk3V6rOWWaivFbTWHdNjBIUTEFini0AGzh5yvQ130_provenance.
• NP946376.RA2KpQUe004IBwefn__60rIXxd2hRD1JMPp6GxkvJM_GU130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946376.RA2KpQUe004IBwefn__60rIXxd2hRD1JMPp6GxkvJM_GU130_provenance.